http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2111856-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_904638586780d4fe7d20a58fae33f8ff |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-20 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-20 |
| filingDate | 1971-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8775e580ce7018be01830e77494ba65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7f8e02a1d85d3be693890affa2087ce |
| publicationDate | 1972-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-2111856-A1 |
| titleOfInvention | Vitamin-E-magnesium-adenosine-5-phosphoric acid salts, their production and application |
| abstract | alpha, beta, gamma or delta - Tocopherol salts of the general formula (I): (where R is H or ch3) reduce the ageing process, tranquilise without sedation and eliminate "medicament stress". The non-toxic salt (I) facilitates absorption of the sparingly absorbable adenosine-5-phosphoric acid by combination with lipoid-soluble vitamin E. They are prepd. from tocopherol-mono-succinic acid and adenosine-5-phosphoric acid with MgCl2 in alcohols in presence of NH3. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10071112-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3204004-A4 |
| priorityDate | 1971-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 62.